ATyr Pharma shares gained after its experimental treatment for an inflammatory lung disease passed another safety checkpoint. The stock rose 8% to $3.34 on Friday. It has more than doubled in the past ...

In a new statement on Thursday, Norway's palace gave an update on her health. It said that she has "daily symptoms and ...

Marit's chronic lung disease is affecting "her ability to perform her duties," the Royal House of Norway announced.

SINGAPORE: A new study from Duke-NUS Medical School has identified a promising new avenue for tackling pulmonary fibrosis, a severe lung condition that progress ...

The Norwegian Royal Court confirmed today that 51-year-old Mette-Marit is having daily symptoms due to her pulmonary fibrosis ...

Crown Princess Mette-Marit of Norway is experiencing daily symptoms from her chronic lung disease, pulmonary fibrosis, which ...

Palace has shared shocking news about Norway's Crown Princess as her health condition deteriorates.Mette-Marit will step back ...

Princess Mette-Marit announced in October 2018 that she had been diagnosed with a rare form of pulmonary fibrosis. Read more ...

Crown Princess Mette-Marit is rearranging her royal responsibilities as her chronic lung disease has "progressed," the Royal ...

The incidence of active pulmonary tuberculosis (PTB) and silicosis among gold miners remains high, but recent years have seen ...

An expert in connective tissue disease–associated interstitial lung disease described best approaches for rheumatologists to ...